Synthomer (LON:SYNT) Share Price Passes Below 200 Day Moving Average – Time to Sell?

Synthomer plc (LON:SYNTGet Free Report)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 126.81 ($1.72) and traded as low as GBX 108.80 ($1.47). Synthomer shares last traded at GBX 114.60 ($1.55), with a volume of 182,693 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank lowered Synthomer to a “hold” rating and decreased their target price for the stock from GBX 230 ($3.12) to GBX 150 ($2.03) in a research report on Wednesday, March 12th.

Get Our Latest Analysis on Synthomer

Synthomer Price Performance

The firm has a market cap of £189.85 million, a price-to-earnings ratio of -2.32, a PEG ratio of -0.17 and a beta of 1.79. The company’s fifty day moving average is GBX 94.63 and its 200 day moving average is GBX 126.81. The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 78.27.

Synthomer (LON:SYNTGet Free Report) last posted its quarterly earnings results on Wednesday, March 12th. The company reported GBX (3.50) (($0.05)) earnings per share for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. On average, equities research analysts predict that Synthomer plc will post 12.962963 EPS for the current year.

Synthomer Company Profile

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.

Headquartered in London, UK and listed on the LSE since 1971, we employ c.4,000 employees across our five innovation centres of excellence and 30 manufacturing sites across Europe, North America, Middle East and Asia.

Featured Stories

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.